Report

reporttype1receiptdateformat102companynumbUS-GILEAD-2014-0101089occurcountryUSVersion of Safety Report ID3receivedateformat102duplicate1transmissiondateformat102fulfillexpeditecriteria1Safety Report ID10152801Date Received05/05/2014transmissiondate12/12/2014serious2Date Last Updated19/05/2014primarysourcecountryUS

Receiver

receivertype6receiverorganizationFDA

Primary Source

reportercountryUSqualification1

Sender

sendertype2senderorganizationFDA-Public Use

Patient

SexMale

Reaction

1)

reactionmeddraversionpt17.0ReactionAngerOutcomeUnknown

2)

reactionmeddraversionpt17.0ReactionEmotional disorderOutcomeUnknown

3)

reactionmeddraversionpt17.0ReactionAbnormal behaviourOutcomeUnknown

4)

reactionmeddraversionpt17.0ReactionAggressionOutcomeUnknown

5)

reactionmeddraversionpt17.0ReactionMental disorderOutcomeUnknown

6)

reactionmeddraversionpt17.0ReactionAgitationOutcomeUnknown

7)

reactionmeddraversionpt17.0ReactionAnxietyOutcomeUnknown

8)

reactionmeddraversionpt17.0ReactionIrritabilityOutcomeUnknown

Drug

1)

drugcharacterization1medicinalproductSOVALDIdrugauthorizationnumb204671drugdosagetextUNKdrugdosageformTABLETdrugadministrationroute065drugindicationHEPATITIS Cdrugstartdateformat102drugstartdate07/02/2014actiondrug5

openFDA Info on Medication

Application NumberNDA204671, NDA212480Brand NameSOVALDIGeneric NameSOFOSBUVIRManufacturersGilead Sciences, Inc.product_ndc61958-1501, 61958-1503, 61958-1504, 61958-1505Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSOFOSBUVIRRXCUI1484916, 1484922, 2203891, 2203893, 2203993, 2203999, 2204090, 2204092spl_idb6ff385d-224a-0bad-e053-2995a90adcd4spl_set_id80beab2c-396e-4a37-a4dc-40fdb62859cfPackage NDC61958-1501-1, 61958-1503-1, 61958-1504-1, 61958-1505-1NUIN0000191493, N0000191258, N0000175459Established Pharmacologic ClassHepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]Mechanism of ActionRNA Replicase Inhibitors [MoA]UNIIWJ6CA3ZU8B

2)

drugcharacterization2medicinalproductRIBAVIRINdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA018859, ANDA077094, ANDA207366, ANDA077224, ANDA079111, ANDA079117, NDA021546Brand NameVIRAZOLE, RIBAVIRIN, REBETOLGeneric NameRIBAVIRINManufacturers Bausch Health US, LLC, Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) In ... product_ndc 0187-0007, 65841-046, 65841-603, 65841-632, 65841-129, 68382-046, 68382-127, 683 ... Product TypeHUMAN PRESCRIPTION DRUGRouteRESPIRATORY (INHALATION), ORALActive IngredientsRIBAVIRINRXCUI207406, 312818, 248109, 597718, 597722, 790286, 312817, 248112, 352007, 544400spl_id 73a3e060-c827-40d8-925c-2d02b9313070, 1596fe48-b374-4c0c-b2ae-1ceb802ca2ba, b46a ... spl_set_id adf16e64-345f-469a-b987-3fbdd17e0ac2, 666e8b22-f519-460b-a774-88a621d56139, 0899 ... Package NDC 0187-0007-14, 0187-0007-01, 65841-046-03, 65841-046-28, 65841-046-10, 65841-046- ... NUIN0000175459, N0000175466Established Pharmacologic ClassNucleoside Analog Antiviral [EPC]UNII49717AWG6K

3)

drugcharacterization2medicinalproductZOLOFTdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA020990, NDA019839Brand NameZOLOFTGeneric NameSERTRALINE HYDROCHLORIDEManufacturersRoerigproduct_ndc0049-0050, 0049-4960, 0049-4900, 0049-4910Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSERTRALINE HYDROCHLORIDERXCUI208149, 208161, 212233, 312938, 312940, 312941, 861064, 861066spl_id665a145d-44fb-4fef-a3c1-2aac26e0715cspl_set_idfe9e8b7d-61ea-409d-84aa-3ebd79a046b5Package NDC 0049-4960-30, 0049-4960-50, 0049-4900-30, 0049-4900-66, 0049-4900-73, 0049-4900- ... UNIIUTI8907Y6X

4)

drugcharacterization2medicinalproductATIVANdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA017794, NDA018140Brand NameATIVANGeneric NameLORAZEPAMManufacturersBausch Health US LLC, West-Ward Pharmaceuticals Corp.product_ndc0187-0063, 0187-0064, 0187-0065, 0641-6000, 0641-6001, 0641-6003, 0641-6002Product TypeHUMAN PRESCRIPTION DRUGRouteORAL, INTRAMUSCULAR, INTRAVENOUSActive IngredientsLORAZEPAMspl_idb87ffa4d-6634-4d66-a907-3eba6911444c, 30a1b292-640f-477d-b193-f564e84d0436spl_set_id89057c93-8155-4040-acec-64e877bd2b4c, 5fc0e987-61c9-40c4-b0d5-fcea07c8733ePackage NDC 0187-0063-01, 0187-0063-50, 0187-0063-10, 0187-0064-01, 0187-0064-50, 0187-0064- ... NUIN0000175694, M0002356Established Pharmacologic ClassBenzodiazepine [EPC]Chemical StructureBenzodiazepines [CS]UNIIO26FZP769LRXCUI206819, 206820, 238100, 238101, 1665188, 1665190, 1665326, 1665327

5)

drugcharacterization2medicinalproductABILIFYdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA021436Brand NameABILIFYGeneric NameARIPIPRAZOLEManufacturersOtsuka America Pharmaceutical, Inc.product_ndc 59148-006, 59148-007, 59148-008, 59148-009, 59148-010, 59148-011, 59148-013, 591 ... Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsARIPIPRAZOLERXCUI 349490, 349545, 349547, 349553, 352307, 352308, 352309, 352310, 402131, 404602, ... spl_id85ae6d7d-eb0f-44b1-bb1f-b58d196124a4spl_set_idc040bd1d-45b7-49f2-93ea-aed7220b30acPackage NDC 59148-006-13, 59148-006-92, 59148-007-13, 59148-007-35, 59148-007-94, 59148-008- ... NUIN0000175430Established Pharmacologic ClassAtypical Antipsychotic [EPC]UNII82VFR53I78

6)

drugcharacterization2medicinalproductATRIPLAdrugdosageformTABLETdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA021937Brand NameATRIPLAGeneric NameEFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATEManufacturersGilead Sciences, LLCproduct_ndc15584-0101Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsEFAVIRENZ, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATERXCUI643066, 643070spl_idb670fd52-7f65-e416-e053-2a95a90ac7b7spl_set_id2e97aa6d-09f7-46df-9499-63db7e9bac35Package NDC15584-0101-1NUI N0000175463, N0000175460, N0000009948, N0000190118, N0000187064, N0000185504, N0 ... Established Pharmacologic Class Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhib ... Mechanism of Action Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Cytochrome P450 3A Induce ... Chemical StructureNucleoside Analog [Chemical/Ingredient]UNIIJE6H2O27P8, G70B4ETF4S, OTT9J7900I

7)

drugcharacterization2medicinalproductPROZACdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA018936Brand NamePROZACGeneric NameFLUOXETINE HYDROCHLORIDEManufacturersDista Products Companyproduct_ndc0777-3104, 0777-3105, 0777-3107Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsFLUOXETINE HYDROCHLORIDERXCUI104849, 205535, 261287, 310384, 310385, 313989spl_idef027dfe-1ccd-4c52-ad10-c76d6834d10cspl_set_idc88f33ed-6dfb-4c5e-bc01-d8e36dd97299Package NDC0777-3104-02, 0777-3105-02, 0777-3105-07, 0777-3105-30, 0777-3107-30UNIII9W7N6B1KJ

Report Duplicate

duplicatesourceGILEADduplicatenumbUS-GILEAD-2014-0101089

Adverse Event Report

Report

Receiver

Primary Source

Sender

Patient

Reaction

1)

2)

3)

4)

5)

6)

7)

8)

Drug

1)

openFDA Info on Medication

2)

openFDA Info on Medication

3)

openFDA Info on Medication

4)

openFDA Info on Medication

5)

openFDA Info on Medication

6)

openFDA Info on Medication

7)

openFDA Info on Medication

Report Duplicate

Media

Newsletter

Follow us

Connect with us